Online Neurology Days | Day 4 | Multiple Sclerosis
Worldwide 2.8 million people are living with multiple sclerosis which is an unpredictable and often disabling disease with no cure. A growing arsenal of disease-modifying therapies offers opportunities to reduce disability and extend survival, but for maximal benefit biomarkers are needed. A complete picture of multiple sclerosis requires combination of markers of inflammation and neurodegeneration. We will paint that picture by sharing diagnostic strategies for imaging neuroinflammatory disease in routine clinical practice as well as offering a window into the brain using optical coherence tomography (OCT).
This webinar will focus on the basics and latest diagnostic advancements with MRI and how Eye Care plays an essential part in diagnosing the progress of MS patients.
Speaker
Dr. Benoît Doche de Laquintane
Radiologist
Medical Imaging group IMAGIR Bordeaux, France
Prof. Bart van Wijmeersch
Neurologist-Immunologist
Medical Head of the Univeristy MS Centre, Pelt Universitair MS Centrum, Hasselt-Pelt ; Noorderhart hospitals, Revalidation & MS, Pelt ; Hasselt University Pelt-Hasselt, Belgium
Prof. Thomas Tourdias
Professor of Radiology
Head of research Institute Bio Imaging Bordeaux University Hospital Bordeaux, FranceCourse Information
By the end of this session, delegates will
- Overview of current best practice for MRI in Multiple Sclerosis.
- Learn more about the possibilities OCT has for MS prognosis, follow-up and treatment response.
- To be aware of non-conventional MRI methods to capture grey matter alterations in MS.
This educational talk was created in September 2021. All information contained in this session was correct at the time of distribution.
Disclaimer: Appearing on the Canon Medical Academy does not represent a commercial partnership or interest from the speaker. The views herein do not represent the views of Canon Medical Systems Ltd.
